- Home
- LYFT vs ICUI Comparison
LYFT vs ICUI Comparison
Compare LYFT & ICUI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LYFT
- ICUI
- Stock Information
- Founded
- LYFT 2007
- ICUI 1984
- Country
- LYFT United States
- ICUI United States
- Employees
- LYFT N/A
- ICUI N/A
- Industry
- LYFT Business Services
- ICUI Medical/Dental Instruments
- Sector
- LYFT Consumer Discretionary
- ICUI Health Care
- Exchange
- LYFT Nasdaq
- ICUI Nasdaq
- Market Cap
- LYFT 5.9B
- ICUI 3.8B
- IPO Year
- LYFT 2019
- ICUI 1992
- Fundamental
- Price
- LYFT $12.97
- ICUI $161.08
- Analyst Decision
- LYFT Buy
- ICUI Buy
- Analyst Count
- LYFT 36
- ICUI 4
- Target Price
- LYFT $17.78
- ICUI $199.67
- AVG Volume (30 Days)
- LYFT 13.8M
- ICUI 200.3K
- Earning Date
- LYFT 02-11-2025
- ICUI 02-25-2025
- Dividend Yield
- LYFT N/A
- ICUI N/A
- EPS Growth
- LYFT N/A
- ICUI N/A
- EPS
- LYFT N/A
- ICUI N/A
- Revenue
- LYFT $5,460,324,000.00
- ICUI $2,340,097,000.00
- Revenue This Year
- LYFT $34.12
- ICUI $4.38
- Revenue Next Year
- LYFT $15.02
- ICUI $0.34
- P/E Ratio
- LYFT N/A
- ICUI N/A
- Revenue Growth
- LYFT 25.41
- ICUI 4.04
- 52 Week Low
- LYFT $8.93
- ICUI $86.80
- 52 Week High
- LYFT $20.82
- ICUI $196.26
- Technical
- Relative Strength Index (RSI)
- LYFT 36.88
- ICUI 51.79
- Support Level
- LYFT $12.58
- ICUI $151.92
- Resistance Level
- LYFT $14.88
- ICUI $167.49
- Average True Range (ATR)
- LYFT 0.53
- ICUI 4.52
- MACD
- LYFT -0.01
- ICUI 0.73
- Stochastic Oscillator
- LYFT 16.96
- ICUI 61.01
About LYFT Lyft Inc.
Lyft is the second-largest ride-hailing service provider in the us and Canada, connecting riders and drivers over the Lyft app. Incorporated in 2013 and public since 2019, Lyft offers a variety of rides via private vehicles, including traditional private rides, shared rides, and luxury ones. Besides ride-hailing, Lyft has entered the bike- and scooter-share market to bring multimodal transportation options to users.
About ICUI ICU Medical Inc.
ICU Medical is a California-based pure-play infusion therapy company that provides consumables, systems, and services for virtually every component of the IV continuum of care. ICU has become one of the largest players in its industry following its acquisition of Hospira Infusion Systems from Pfizer in 2017 and Smiths Medical from Smiths Group in 2022. It holds top-tier positions across its three reporting segments: consumables (43% of consolidated revenue), infusion systems (28%), and vital care (29%). The combined entity remains primarily US-focused, generating over 63% of its sales domestically.